Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 20/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 19/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29842732 | 1.00 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL20702876 | 1.00 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL20702583 | 1.00 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL20705328 | 0.89 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL29842868 | 0.89 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL20702807 | 0.87 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL30692586 | 0.87 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL20702904 | 0.87 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL22697068 | 0.86 | PDE3B (1.00) | PDE3BPDE3A | |
| SCHEMBL26364082 | 0.86 | PDE3B (1.00) | PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4301371-A1 | SUBSTITUTED 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES FOR THE TREATMENT OF SARCOMA | Bayer Aktiengesellschaft (DE) | 2024-01-10 | — | — | EP | claimed |
| CN-117279644-A | Substituted 3, 6-dihydro-2H-1, 3, 4-oxadiazin-2-ones for the treatment of sarcomas | 拜耳股份有限公司 | 2023-12-22 | — | — | CN | claimed |
| WO-2022184748-A1 | SUBSTITUTED 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES FOR THE TREATMENT OF SARCOMA | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-09 | — | — | WO | claimed |
| CN-117279644-A | Substituted 3, 6-dihydro-2H-1, 3, 4-oxadiazin-2-ones for the treatment of sarcomas | 拜耳股份有限公司 | 2023-12-22 | — | — | CN | disclosed |